Search results for “Chronic inflammatory disorder” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,556 patents, we discovered top 229 key players by total patent application. Boehringer Ingelheim Pharmaceuticals, Inc., Schering Corp., Nestec SA are dominant in this area. They take 16.90% of the total patent filing.
Boehringer Ingelheim Pharmaceuticals, Inc.
Connecticut, United States
Patent: 166
Schering Corp.
New Jersey, United States
Patent: 54
Nestec SA
Vaud, Switzerland
Patent: 43
Pharmacopeia LLC
New Jersey, United States
Patent: 35
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 28
Ivax Drug Research Institute LLC
Hungary
Patent: 28
Abbott Laboratories
Illinois, United States
Patent: 27
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 27
Glaxo Group Ltd.
Hounslow, United Kingdom
Patent: 27
Novartis AG
Basel-Stadt, Switzerland
Patent: 26
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 20 patents, we discovered top 3 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 8
STARTUP
XinThera, Inc.
California, United States
Patent: 6
STARTUP
Aardvark Therapeutics, Inc.
California, United States
Patent: 6
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 156 patents applied in the last 5 years. We discover 44 most active companies in this area. The fast-growing MetiMedi Pharmaceuticals Co. Ltd., LG Chem Ltd., XinThera, Inc. take 15.38% of patent filing during this period.
MetiMedi Pharmaceuticals Co. Ltd.
South Korea
Patent: 12
LG Chem Ltd.
South Korea
Patent: 6
STARTUP
XinThera, Inc.
California, United States
Patent: 6
STARTUP
Aardvark Therapeutics, Inc.
California, United States
Patent: 6
Repos Pharma AB
Sweden
Patent: 6
Cypralis Ltd.
Cambridgeshire, United Kingdom
Patent: 5
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Germany
Patent: 5
Regents of The University of Michigan
Michigan, United States
Patent: 4
Council of Scientific & Industrial Research
Delhi, India
Patent: 4
Hokkaido University
Hokkaido, Japan
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 156 patents in last 5 years, we discover 24 new entrants. MetiMedi Pharmaceuticals Co. Ltd., Repos Pharma AB, XinThera, Inc. are the most active new entrants in this area.
MetiMedi Pharmaceuticals Co. Ltd.
South Korea
Patent: 12
Repos Pharma AB
Sweden
Patent: 6
STARTUP
XinThera, Inc.
California, United States
Patent: 6
STARTUP
Aardvark Therapeutics, Inc.
California, United States
Patent: 6
Cypralis Ltd.
Cambridgeshire, United Kingdom
Patent: 5
Council of Scientific & Industrial Research
Delhi, India
Patent: 4
Hokkaido University
Hokkaido, Japan
Patent: 4
BioInvent International AB
Sweden
Patent: 4
Celagenex Research India Pvt Ltd
United States
Patent: 3
Shanghai Weishen Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 3
Research Institutions
Order by:
Innovation Intensity
With the analysis among 297 patents, we discovered top 50 universities and scientific research institutions by total patent application. Vanderbilt University, University of Birmingham, University of British Columbia are dominant in this area. They take 16.50% of the total patent filing.
Vanderbilt University
Tennessee, United States
Patent: 11
University of Birmingham
Birmingham, United Kingdom
Patent: 10
University of British Columbia
British Columbia, Canada
Patent: 9
Washington University in St. Louis
Missouri, United States
Patent: 9
Gwangju Institute of Science & Technology
South Korea
Patent: 7
École Polytechnique Fédérale de Lausanne
Vaud, Switzerland
Patent: 6
Council of Scientific & Industrial Research
Delhi, India
Patent: 4
University College London
United Kingdom
Patent: 4
Hokkaido University
Hokkaido, Japan
Patent: 4
University of Strasbourg
France
Patent: 4
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: